免疫萬公司
US ˙ NasdaqGS ˙ US45258J1025

SecurityIMVT / Immunovant, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership6,574,497 shares
Latest Disclosed Value $ 163,310,512
BlackRock, Inc. reports 8.52% increase in ownership of IMVT / Immunovant, Inc.

On May 13, 2026 - BlackRock, Inc. filed a 13F-HR form disclosing ownership of 6,574,497 shares of Immunovant, Inc. (US:IMVT) valued at $163,310,505 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 6,058,216 shares of Immunovant, Inc.. This represents a change in shares of 8.52% during the quarter. The current value of the position is $214,788,817 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F IMMUNOVANT COM 45258J102 6,574,497 516,281 8.52 163,311 6.05 0.0029
2026-02-12 2025-12-31 13F IMMUNOVANT COM 45258J102 6,058,216 319,980 5.58 154,000 66.49 0.0026
2025-11-12 2025-09-30 13F IMMUNOVANT COM 45258J102 5,738,236 -110,049 -1.88 92,500 -1.15 0.0016
2025-08-12 2025-06-30 13F IMMUNOVANT COM 45258J102 5,848,285 484,063 9.02 93,573 2.07 0.0018
2025-05-02 2025-03-31 13F IMMUNOVANT COM 45258J102 5,364,222 221,151 4.30 91,675 -28.04 0.0019
2025-02-07 2024-12-31 13F IMMUNOVANT COM 45258J102 5,143,071 89,921 1.78 127,394 -11.57 0.0026
2024-11-13 2024-09-30 13F IMMUNOVANT COM 45258J102 5,053,150 137,023 2.79 144,065 11.00 0.0030
2024-08-13 2024-06-30 13F IMMUNOVANT COM 45258J102 4,916,127 439,327 9.81 129,786 -10.27 0.0029
2024-05-10 2024-03-31 13F IMMUNOVANT COM 45258J102 4,476,800 -53,916 -1.19 144,645 -24.22 0.0034
2024-02-13 2023-12-31 13F IMMUNOVANT COM 45258J102 4,530,716 399,051 9.66 190,879 20.34 0.0049
2023-11-13 2023-09-30 13F IMMUNOVANT COM 45258J102 4,131,665 -69,649 -1.66 158,615 99.02 0.0046
2023-08-11 2023-06-30 13F IMMUNOVANT COM 45258J102 4,201,314 264,133 6.71 79,699 30.51 0.0022
2023-05-12 2023-03-31 13F IMMUNOVANT COM 45258J102 3,937,181 7,757 0.20 61,066 -12.45 0.0018
2023-02-13 2022-12-31 13F IMMUNOVANT COM 45258J102 3,929,424 422,750 12.06 69,747 256.43 0.0022
2022-11-14 2022-09-30 13F IMMUNOVANT COM 45258J102 3,506,674 -124,636 -3.43 19,568 38.17 0.0007
2022-08-12 2022-06-30 13F IMMUNOVANT COM 45258J102 3,631,310 277,444 8.27 14,162 -23.36 0.0005
2022-05-12 2022-03-31 13F IMMUNOVANT COM 45258J102 3,353,866 28,865 0.87 18,479 -34.77 0.0005
2022-02-10 2021-12-31 13F IMMUNOVANT COM 45258J102 3,325,001 76,000 2.34 28,328 0.33 0.0007
2021-11-09 2021-09-30 13F IMMUNOVANT COM 45258J102 3,249,001 146,214 4.71 28,234 -13.91 0.0008
2021-08-11 2021-06-30 13F IMMUNOVANT COM 45258J102 3,102,787 -582,229 -15.80 32,796 -44.52 0.0009
2021-05-07 2021-03-31 13F IMMUNOVANT COM 45258J102 3,685,016 -1,114,571 -23.22 59,109 -73.34 0.0017
2021-02-05 2020-12-31 13F IMMUNOVANT COM 45258J102 4,799,587 1,270,446 36.00 221,694 78.51 0.0071
2020-11-06 2020-09-30 13F IMMUNOVANT COM 45258J102 3,529,141 1,226,550 53.27 124,191 121.50 0.0046
2020-08-14 2020-06-30 13F IMMUNOVANT COM 45258J102 2,302,591 1,399,624 155.00 56,068 298.92 0.0022
2020-05-01 2020-03-31 13F IMMUNOVANT COM 45258J102 902,967 303,100 50.53 14,055 47.64 0.0007
2020-02-13 2019-12-31 13F IMMUNOVANT COM 45258J102 599,867 599,867 9,520 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.